Carvedilol

Atrial Fibrillation, Ventricular Dysfunction, Left, Heart failure + 5 more

Treatment

9 FDA approvals

20 Active Studies for Carvedilol

What is Carvedilol

Carvedilol

The Generic name of this drug

Treatment Summary

Carvedilol is a medication used to treat heart failure, left ventricular dysfunction, and high blood pressure. It works by blocking the action of certain hormones in the body that can cause the heart rate to increase. Carvedilol is unique in that it is a combination of two drugs, which can be used together to reduce the risk of side effects compared to using a single high-dose drug. Carvedilol was approved by the FDA in 1995.

Coreg

is the brand name

image of different drug pills on a surface

Carvedilol Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Coreg

Carvedilol

1997

522

Approved as Treatment by the FDA

Carvedilol, commonly known as Coreg, is approved by the FDA for 9 uses such as Ventricular Dysfunction, Left and Heart failure .

Ventricular Dysfunction, Left

Helps manage LVEF ≤40% Left ventricular dysfunction

Heart failure

Helps manage NYHA Class I or II heart failure

chronic heart failure with reduced ejection fraction (NYHA Class IV)

Helps manage chronic heart failure with reduced ejection fraction (NYHA Class IV)

NYHA Class I or II heart failure

Helps manage NYHA Class I or II heart failure

Hypesthesia

Helps manage chronic heart failure with reduced ejection fraction (NYHA Class III)

LVEF ≤40% Left ventricular dysfunction

Helps manage LVEF ≤40% Left ventricular dysfunction

Hypertensive disease

Helps manage High Blood Pressure (Hypertension)

Hypesthesia

Helps manage chronic heart failure with reduced ejection fraction (NYHA Class IV)

Heart Attack

Helps manage Myocardial Infarction

Effectiveness

How Carvedilol Affects Patients

Carvedilol works by blocking certain hormones that can cause your heart to beat too fast and your blood pressure to rise. It usually needs to be taken once a day and is considered to be safe if taken in the proper dose (10-80mg daily). It is important not to suddenly stop taking it, as this can make existing coronary artery disease worse.

How Carvedilol works in the body

Carvedilol works to reduce blood pressure by blocking the action of certain receptors that cause constriction of blood vessels. It also helps to prevent the buildup of cholesterol in the arteries. At higher doses, it can also block calcium channels and have an antioxidant effect, which helps protect against cell damage.

When to interrupt dosage

The measure of Carvedilol is contingent upon the detailed state, including Chronic Stable Angina Pectoris, Ventricular Dysfunction, Left and Hypesthesia. The quantity of dosage is contingent upon the delivery approach noted in the following table.

Condition

Dosage

Administration

Atrial Fibrillation

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Ventricular Dysfunction, Left

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Heart failure

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Hypesthesia

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Hypesthesia

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Heart Attack

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Hypertensive disease

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Angina, Stable

, 10.0 mg, 20.0 mg, 40.0 mg, 80.0 mg, 3.125 mg, 6.25 mg, 12.5 mg, 25.0 mg, 0.125 mg, 50.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Tablet, coated, Tablet, coated - Oral, Kit

Warnings

Carvedilol Contraindications

Condition

Risk Level

Notes

Bronchospasm

Do Not Combine

Asthma

Do Not Combine

Sick Sinus Syndrome

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Therapeutic procedure

Do Not Combine

Therapeutic procedure

Do Not Combine

severe bradycardia

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Carvedilol may interact with Pulse Frequency

Atrioventricular Block

Do Not Combine

There are 20 known major drug interactions with Carvedilol.

Common Carvedilol Drug Interactions

Drug Name

Risk Level

Description

4-Bromo-2,5-dimethoxyphenethylamine

Major

The therapeutic efficacy of 4-Bromo-2,5-dimethoxyphenethylamine can be decreased when used in combination with Carvedilol.

4-Methoxyamphetamine

Major

The therapeutic efficacy of 4-Methoxyamphetamine can be decreased when used in combination with Carvedilol.

Abediterol

Major

The therapeutic efficacy of Abediterol can be decreased when used in combination with Carvedilol.

Abemaciclib

Major

The serum concentration of Abemaciclib can be increased when it is combined with Carvedilol.

Acepromazine

Major

Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Carvedilol Toxicity & Overdose Risk

An overdose of the drug can cause low blood pressure, slow heartbeat, heart weakness, shock, and cardiac arrest. Patients should lie down and may be given atropine to raise the heart rate and glucagon and other medicines to help treat the cardiovascular issues.

image of a doctor in a lab doing drug, clinical research

Carvedilol Novel Uses: Which Conditions Have a Clinical Trial Featuring Carvedilol?

253 active investigations are investigating the potential of Carvedilol to diminish Hypesthesia, treat Heart failure, and reduce Hypesthesia in affected individuals.

Condition

Clinical Trials

Trial Phases

Atrial Fibrillation

103 Actively Recruiting

Not Applicable, Phase 4, Phase 1, Phase 3, Phase 2, Early Phase 1

Hypertensive disease

41 Actively Recruiting

Not Applicable, Phase 3, Phase 1, Phase 2

Heart Attack

25 Actively Recruiting

Not Applicable, Early Phase 1, Phase 4, Phase 2, Phase 3

Angina, Stable

0 Actively Recruiting

Hypesthesia

11 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Heart failure

0 Actively Recruiting

Hypesthesia

4 Actively Recruiting

Not Applicable, Phase 1

Ventricular Dysfunction, Left

0 Actively Recruiting

Carvedilol Reviews: What are patients saying about Carvedilol?

4.3

Patient Review

8/21/2021

Carvedilol for Prevention of Recurrent Atrial Fibrillation

I've only been taking this medication for a little while, but it has already lowered my blood pressure and slowed down my breathing. I have noticed some drowsiness, but it also allows me to breathe more deeply and without the chest tightness I used to feel. For now, I think the benefits outweigh the drawbacks.

2.7

Patient Review

5/3/2021

Carvedilol for High Blood Pressure

I get nose bleeds often and I think it has to do with this blood pressure medication. If anyone else has had a similar experience, please let me know.

2.3

Patient Review

4/3/2020

Carvedilol for Chronic Heart Failure

I've been on this medication for a year now, and I keep telling my doctor that it's not good. I'm constantly tired and sweaty, and it's hard to stay awake. I'm going to see the cardiologist again soon to discuss changing or discontinuing the medication so that I can live a better quality life.

2.3

Patient Review

2/10/2021

Carvedilol for High Blood Pressure

I have yet to see any significant changes in my blood pressure after taking this medication for two months now.

2

Patient Review

11/13/2020

Carvedilol for High Blood Pressure

I was on this medicine for a month at 6.25mg, then my cardiologist increased the dosage to 12.5mg twice daily. I started experiencing severe chest pain, dizziness, and headaches so I will be asking my doctor to change my medication.

1.7

Patient Review

4/13/2022

Carvedilol for Dysfunction of Left Ventricle of Heart following Heart Attack

I had to stop taking this drug after just two weeks because the side effects were so extreme. I was constantly dizzy, having trouble breathing, and my mouth was always dry. My blood pressure was also very low. If you have any chronic health conditions, I would not recommend this drug.

1.7

Patient Review

10/27/2022

Carvedilol for High Blood Pressure

After my second dose of 3.125mg, I felt an overwhelming sense of anger which was quickly followed by sadness and depression. I had suicidal and homicidal thoughts.

1.3

Patient Review

5/12/2021

Carvedilol for Prevention of Recurrent Atrial Fibrillation

I'm really tired of feeling this way. I hate how it makes my skin feel, and I'm cold all the time. I just want to be off of it.

1

Patient Review

8/5/2021

Carvedilol for High Blood Pressure

I was prescribed this pill and have been taking it for two years now. I'm constantly tired and wheeze regularly. My mom was also prescribed this pill and she used to be exhausted all the time; she even died as a result of exhaustion-related falls. I spoke to a pharmacist about my concerns and they told me not to take the pill anymore and to consult with a doctor who actually cares.

1

Patient Review

3/18/2022

Carvedilol for High Blood Pressure

I started taking this medication on September 21st at a dose of 6.25mg. Unfortunately, that wasn't enough and my cardiologist put me up to 12.25mg. I then dropped back down to 6.25mg and my blood pressure is good now. However, I experienced a lot of side effects like dizziness, tiredness, fluid retention, weight gain, shortness of breath, etc. My advice is to make sure you have an excellent PCP and cardiologist before starting this journey.

1

Patient Review

1/9/2022

Carvedilol for Prevention of Recurrent Atrial Fibrillation

I'm Asian and I started taking this medication in September of 2020 to help with my heart palpitations. While it did lower the palpitation, I started experiencing dizziness, muscle pain, and blurry vision by November. This was the only new medication I was taking at the time, so I'm confident that it was the cause. I stopped taking it a few days ago, and while the dizziness is more manageable now, it still comes and goes.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about carvedilol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is a carvedilol used for?

"Carvedilol is a medicine used to treat high blood pressure and prevent angina, heart disease and stroke."

Answered by AI

What are the side effects of carvedilol?

"Allergy, chest pain, discomfort, tightness, heaviness, dizziness, lightheadedness, fainting, generalized swelling, swelling of feet, ankles, lower legs, pain, slow heartbeat, weight gain."

Answered by AI

Is carvedilol a beta-blocker or diuretic?

"The response to carvedilol is not diminished on chronic administration.

Carvedilol is a new antihypertensive agent that blocks beta receptors and also has vasodilating properties due to its alpha 1-blocking activity. This results in reduced peripheral vascular resistance, but cardiac output and renal function are not affected. The response to carvedilol does not decrease over time with continued use."

Answered by AI

Who should not take carvedilol?

"Medical conditions that may cause problems with the electrical signals in the heart include diabetes, myasthenia gravis (a disorder that causes muscle weakness), Prinzmetal angina (a type of chest pain that occurs when at rest), complete heart block, second degree atrioventricular heart block, sick sinus syndrome, and sinus bradycardia (a slow heart rhythm)."

Answered by AI

Clinical Trials for Carvedilol

Image of Caridad Center, Inc. in Boynton Beach, United States.

CHW Nutrition Support for Type 2 Diabetes

18+
All Sexes
Boynton Beach, FL

This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit. Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.

Waitlist Available
Has No Placebo

Caridad Center, Inc.

Janet Diaz Martinez

Image of Satellite Healthcare - Daly City in San Francisco, United States.

Blood Pressure Management for Kidney Failure

18+
All Sexes
San Francisco, CA

The GOAL-BP pilot study will help determine whether a study comparing two blood pressure goals can be carried out in adults with end-stage kidney disease and high blood pressure who receive peritoneal dialysis. The main questions it aims to answer are whether eligible patients can be recruited for the study. Researchers will compare two goals for the top blood pressure number (systolic blood pressure): below 120 mmHg versus below 140 mmHg.This pilot study will help plan a larger trial in the future. Participants will: * Be assigned by chance to one of the two blood pressure goals. * Have their blood pressure measured at clinic visits about every two weeks. * Work with their kidney doctor on recommended changes to fluid management, peritoneal dialysis treatment, or blood pressure medicines to reach their assigned goal. * Be part of the study for about four and a half months.

Recruiting
Has No Placebo

Satellite Healthcare - Daly City (+2 Sites)

Chi-yuan Hsu, MD, MS

Image of Allegheny General Hospital in Pittsburgh, United States.

Bachmann's Bundle vs Right Atrial Appendage Pacing for Atrial Fibrillation

18+
All Sexes
Pittsburgh, PA

Participants will be randomly assigned to one of two clinical treatment Arms, both of which are standard care procedures performed in the right atrium (RA): Arm A: Pacing from the Bachmann's Bundle (BB) in the right atrium (upper right chamber of the heart) Arm B: Pacing from the right atrial appendage (RAA - a sac attached to the right atrium) Neither of these treatments are experimental; both are routinely performed by Electrophysiologists in the clinical setting. The purpose of this study is to compare side by side these two treatments and evaluate if one is better than the other. After the procedure, participants will be followed for one year. Medical record data will be collected, and a blood sample will be collected upon enrollment and at one year after implantation. Research-related surveys will be completed at the standard-care 3-, 6-, and 12-month visits.

Recruiting
Has No Placebo

Allegheny General Hospital

Joshua Silverstein, MD

Medtronic

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Barber and Pharmacist Coordination for High Blood Pressure

35 - 79
Male
Los Angeles, CA

The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Christine Albert, MD, MPH

Have you considered Carvedilol clinical trials?

We made a collection of clinical trials featuring Carvedilol, we think they might fit your search criteria.
Go to Trials
Image of Cleveland Clinical Foundation in Cleveland, United States.

4D ICE Imaging for Atrial Fibrillation

18+
All Sexes
Cleveland, OH

The purpose of this study is to evaluate the imaging performance and procedural safety of a prototype 4D ICE catheter during real-time intracardiac imaging and to optimize device imaging parameters, compared with current standard imaging modalities. TEE is the current standard of care and will serve as the primary imaging modality for clinical guidance during the EP and Structural Heart Disease (SHD) procedures. In this research protocol, TEE is not being investigated. ICE will be used as an adjunct imaging modality for research data collection and workflow evaluation only. All procedures will be performed using commercially available, FDA-approved Watchman devices, and no investigational implantable devices will be used. The use of ICE in this study does not modify the approved therapeutic device indication, implantation technique, or standard clinical decision-making.

Recruiting
Has No Placebo

Cleveland Clinical Foundation

Walid Saliba, MD

Siemens Corporation, Corporate Technology

Image of Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington in Arlington, United States.

Alcohol Abstinence for High Blood Pressure

26 - 49
All Sexes
Arlington, TX

The purpose of this study is to learn whether avoiding alcohol can improve heart and blood vessel health in adults who regularly drink alcohol and have high blood pressure. High blood pressure is a major risk factor for cardiovascular disease (CVD), including heart attack and stroke. In this randomized, controlled trial, men and women aged 26 to 49 years who regularly consume alcohol and have high blood pressure will be assigned by chance to either stop drinking alcohol or continue their usual drinking habits for 8 weeks. Researchers will compare changes in blood pressure and other cardiovascular disease risk factors between the two groups. The information gained from this study may help researchers and health care providers better understand the effects of alcohol consumption on cardiovascular health and whether alcohol abstinence can reduce heart disease risk, especially in adults with high blood pressure.

Recruiting
Has No Placebo

Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington

Image of Department of Family & Community Medicine; University of Alabama at Birmingham in Birmingham, United States.

Treatment for High Blood Pressure

18+
All Sexes
Birmingham, AL

The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.

Waitlist Available
Has No Placebo

Department of Family & Community Medicine; University of Alabama at Birmingham

Have you considered Carvedilol clinical trials?

We made a collection of clinical trials featuring Carvedilol, we think they might fit your search criteria.
Go to Trials
Image of University of California, Davis in Sacramento, United States.

EchoPixel HTG for Structural Heart Conditions

18+
All Sexes
Sacramento, CA

To investigate and evaluate the benefits of adding EchoPixel Holographic Therapy Guidance to the current standard of care in Structural Heart (SH) procedures. Current structural heart (SH) procedures rely on standard image guidance (SIG) relies on 2D X-plane or multiplanar reformatted (MPR) views that can conceal critical anatomy elements at the time of implant or therapy delivery which are crucial to achieve an optimal long term durable outcome. This limitation complicates an operator's task of optimally implanting a 3D device, delivered by tools that rotate and maneuver in 3D, within a dynamic 3D anatomy, the heart. Slight mismatches between the device and the target in the heart are indicative of a sub-optimal device position, a key risk-factor of peri-device leak (PDL) and other complications. The primary objective of the study is to determine if including EchoPixel - HTG as an additive visualization procedural tool has a positive impact on optimal procedure outcomes for patients undergoing in Structural Heart (SH) procedures.

Waitlist Available
Has No Placebo

University of California, Davis

Gagan D Singh, MD

EchoPixel, Inc.

Image of NeuroFit Lab, Ivor Wynne Centre, McMaster University in Hamilton, Canada.

Isometric Handgrip Exercise for High Blood Pressure

65+
All Sexes
Hamilton, Canada

The goal of this clinical trial is to evaluate whether a short, supervised isometric handgrip exercise program is feasible and acceptable for older adults with elevated blood pressure or hypertension. It will also explore whether this type of exercise may improve blood pressure and cognitive function. The main questions it aims to answer are: * Is this handgrip exercise program practical and acceptable for older adults to participate in within a community exercise setting? * Does participation in the program lead to changes in blood pressure and cognitive function? Researchers will compare two handgrip devices to determine whether the method of delivering the exercise influences feasibility and outcomes. Participants will: * Be randomly assigned to use one of two handgrip devices. * Complete supervised exercise sessions twice per week for 4 weeks. * Perform brief handgrip contractions at a set intensity during each session. * Complete blood pressure and cognitive assessments before and after the program.

Recruiting
Has No Placebo

NeuroFit Lab, Ivor Wynne Centre, McMaster University (+1 Sites)

Jennifer Heisz, PhD

Have you considered Carvedilol clinical trials?

We made a collection of clinical trials featuring Carvedilol, we think they might fit your search criteria.
Go to Trials